All In MedTech

Device Trial Radar · NCT03459196

Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation.

Last checked: Nov 20, 2026Latest source record: Jun 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

54

Actual

Start

Apr 2, 2018

Primary completion

Oct 8, 2018

Study completion Oct 8, 2018

Sponsor

Lead sponsor
Biosense Webster, Inc.Public (JNJ)
Sponsor type
Industry
First posted
Mar 8, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The QDOT-FAST study is a prospective, multi-center, non-randomized, interventional clinical study.

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

  • THERMOCOOL SMARTTOUCH SF-5D CatheterDevice

    radiofrequence ablation with THERMOCOOL SMARTTOUCH® SF-5D catheter used in combination with the nMARQ™ Multi-Channel RF Generator with TGA mode

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects Achieved Acute Procedural SuccessTime frame: Day 1
  2. Incidence of Acute SafetyTime frame: 7 days post-procedure

Locations

7 sites in 4 countries. Site status is shown where the registry gives one.

  • Elisabethinen Hospital

    Linz, Austria

  • OLV Aalst

    Aalst, Belgium

  • AZ Sint-Jan

    Bruges, Belgium

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.